Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) had its price objective dropped by equities researchers at Morgan Stanley from $180.00 to $175.00 in a research note issued on Monday,Benzinga reports. The brokerage presently has an “equal weight” rating on the financial services provider’s stock. Morgan Stanley’s price objective points to a potential upside of 0.60% from the company’s current price.
Several other research analysts have also recently weighed in on the company. Citigroup upgraded Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 price objective on the stock in a research report on Wednesday, May 6th. JPMorgan Chase & Co. lowered their target price on shares of Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating on the stock in a report on Thursday, April 9th. UBS Group lowered their price objective on Marsh & McLennan Companies from $230.00 to $203.00 and set a “buy” rating on the stock in a research note on Tuesday, June 9th. Mizuho cut their price objective on shares of Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating for the company in a research report on Monday, April 13th. Finally, Wells Fargo & Company reduced their price target on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 9th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $199.25.
Marsh & McLennan Companies Trading Down 2.6%
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last announced its quarterly earnings results on Thursday, April 16th. The financial services provider reported $3.29 EPS for the quarter, beating analysts’ consensus estimates of $3.21 by $0.08. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The business had revenue of $7.30 billion for the quarter. The company’s quarterly revenue was up 7.6% on a year-over-year basis. Equities analysts anticipate that Marsh & McLennan Companies will post 10.38 EPS for the current year.
Insider Transactions at Marsh & McLennan Companies
In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,656 shares of the company’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total value of $2,693,441.76. Following the sale, the chief executive officer owned 116,811 shares in the company, valued at approximately $18,889,506.81. The trade was a 12.48% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
Several hedge funds have recently made changes to their positions in MRSH. Solstein Capital LLC acquired a new position in Marsh & McLennan Companies in the fourth quarter valued at approximately $25,000. Asset Dedication LLC bought a new stake in shares of Marsh & McLennan Companies in the 1st quarter valued at $25,000. SHP Wealth Management acquired a new position in shares of Marsh & McLennan Companies during the 4th quarter valued at $26,000. KERR FINANCIAL PLANNING Corp bought a new position in Marsh & McLennan Companies during the fourth quarter worth $27,000. Finally, Golden State Wealth Management LLC acquired a new stake in Marsh & McLennan Companies in the fourth quarter worth $27,000. 87.99% of the stock is owned by institutional investors.
About Marsh & McLennan Companies
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Further Reading
- Five stocks we like better than Marsh & McLennan Companies
- These 3 Stocks Offer Investors Exposure to the Functional Beverage Boom
- Alcoa’s $4.1 Billion South32 Deal: Opportunity Behind the 9% Drop
- 3 High-Yield Dividend Stocks With Real Capital Gains Potential in 2026
- Analysts Just Raised Price Targets On These 3 Semiconductor Equipment Stocks
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
